Metraipolis › archive › dc_5ec24ddc0a67

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical… — Europe PMC PMID:41246132

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41246132
DOI: 10.3389/falgy.2025.1688464
License (as archived): solo-consultazione
Archived: 2026-11-08T22:32:10.266Z
SHA-256 of the archived text: db19269c6d6821e37937ebd1332e08f5aa4c35b31606ba63fa95cb4d3c8a4e72
Stable URL of this page: https://metraipolis.com/documento/dc_5ec24ddc0a67

How to cite

Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical… — Europe PMC PMID:41246132 — Europe PMC (en), https://europepmc.org/article/MED/41246132 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ec24ddc0a67 (Metraipolis archive dc_5ec24ddc0a67, sha256 db19269c6d6821e37937ebd1332e08f5aa4c35b31606ba63fa95cb4d3c8a4e72)

BibTeX

@misc{dc5ec24ddc0a67,
  title = {Predictors of response to omalizumab and relapse in chronic spontaneous Urticaria: a narrative review focusing on parameters available in routine clinical… — Europe PMC PMID:41246132},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41246132},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ec24ddc0a67; sha256 db19269c6d6821e37937ebd1332e08f5aa4c35b31606ba63fa95cb4d3c8a4e72},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41246132. Agents can read the archived copy with the MCP tool read_document.